News - Brightlands Venture Partners

Matisse Pharmaceuticals receives BfArM approval to study a prolonged infusion of M6229

October 24, 2024

Bio-Engineering scale-up Qorium unveils cultivated leather breakthrough, marking major progress toward commercialization

October 23, 2024

Matisse Pharmaceuticals appoints Prof. Carolyn Calfee to the Scientific Board

October 22, 2024

PL BioScience closes € 7.8 million Series A Financing

August 08, 2024

BVP 2023 Impact Report Now Available!

June 27, 2024

Vivalyx secures seed financing to improve donor organ quality

April 30, 2024

Funding for TripleMed to achieve CE marking

March 21, 2024

Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients.

January 30, 2024

Verdify secures €2.4 million investment for impactful food choices in healthcare and retail

January 24, 2024

Funding of Ioniqa’s enhanced recycling business of PET Polyester

January 23, 2024

Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners

January 10, 2024

Matisse Pharmaceuticals closes EUR. 3.6 million financing round.

January 04, 2024

More information

If you have any questions or want to know more about us
Contact us